Catalyst Wire Dossier Catalyst Wire Dossier

YH1885L

· Yuhan Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YH1885L, covering 2014-07-10 to 2014-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD) [Phase 2]

See pricing